A new paper from researchers at mostly Danish institutes found that the M RNA COVID-19 vaccine made by Pfizer and Moderna did not cause a reduction in all-cause mortality in randomized controlled trials. Incidentally COVID-19 vaccines made with older technology which are considered the adenovirus vector vaccines, specifically Johnson and Johnson’s, had a lower overall all caused mortality. This adds to the questions about the basis for the vaccines and booster mandates for 10’s of millions of Americans.
The FDA’s former chief scientists Luciana Borio and the current advisor to pull off it recently stated that they were worried the US policy was headed for annual booster recommendations of the COVID-19 vaccine without any justification due to a lack of data. Dozens of scientists signed a letter to the top FDA official last week asking them to recommend assessments of T cells during the COVID-19 vaccine clinical trials. This in addition to antibody response which is typically short lived. In the Pfizer and Moderna shots specifically antibody responses to the delta and omicron variants have been underperforming.
This is absolutely correct. Giving an annual shot without running a randomized control trial showing improvement in severe disease and hospitalization and even death would be foolish.
Might as well just give a blank check to Bourla
Companies have to prove their products work https://t.co/1W3fk0Qpz2
— Vinay Prasad, MD MPH (@VPrasadMDMPH) April 26, 2022
The Danish paper has not yet undergone formal peer review. However, the former Harvard Medical School professor Martin Kulldorff said that he and others inside the United States and Europe, had reviewed the Danish paper and its data. “Given this pattern of evidence it makes sense to recommend the adenovector vaccines in most cases over the mRNA vaccines, and to ask the mRNA vaccine manufacturers to provide randomized evidence of mortality reduction against an adenovector vaccine,” Bhattacharya wrote in an email.
Just 16 people who received the Johnson and Johnson, AstraZeneca, and Sputnik vaccinations died compared to 30 in the control group. This is a highly significant reduction in overall mortality. Sputnik was the only one to have too few deaths to confidently discern any difference. Pfizer and Moderna make any public statements in response to the research. The FDA and CDC similarly did not say anything in response to the research.
One can conclude from this information that perhaps it is safer to take a traditional older technology vaccine if you must take a vaccine. These would include the Johnson and Johnson vaccination for COVID-19 and the Astra Zeneca vaccination for COVID-19. The Sputnik vaccination for COVID-19 is not available in the United States. Mandating vaccinations that have not been tested properly for millions of Americans should never have been allowed.
In light of this new information, most of the world could follow Denmark’s example. Denmark has become the first country to pause its COVID-19 vaccination program. Health officials in the country say the epidemic has become been brought under control. “Spring has arrived, vaccine coverage in the Danish population is high, and the epidemic has reversed,” the health authority said. “Therefore, the National Board of Health is now ending the broad vaccination efforts against COVID-19 for this season.”
Officials will stop sending out invitations for vaccination by the date of May 15th, 2022. The health authority does still recommend vaccination against COVID-19 for those at greatest risk of serious disease. Citizens of Denmark who are at greatest risk are eligible for a fourth booster. Broad vaccination will continue in the fall officials say as they expect an uptick in seasonal infections.
This story syndicated with permission from For the Love of News
"*" indicates required fields